Home NDC 0409-5086 TAZICEF
Product NDC 0409-5086
11-digit product format 004095086
Labeler code 0409
Product ID 0409-5086_b4cff5d5-d1ec-4959-b062-e754517aab2d
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name CEFTAZIDIME
Dosage form INJECTION, POWDER, FOR SOLUTION
Route INTRAVENOUS
Labeler Hospira, Inc.
Application ANDA062662
Marketing category ANDA
Marketing start 2006-04-20
Substance CEFTAZIDIME
Active strength 6 g/1
Pharmacologic classes Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A062662-001 TAZICEF CEFTAZIDIME 500MG/VIAL INJECTABLE / INJECTION 1986-03-06 A062662-002 TAZICEF CEFTAZIDIME 1GM/VIAL INJECTABLE / INJECTION AP 1986-03-06 A062662-003 TAZICEF CEFTAZIDIME 2GM/VIAL INJECTABLE / INJECTION AP 1986-03-06 A062662-004 TAZICEF CEFTAZIDIME 6GM/VIAL INJECTABLE / INJECTION AP 1986-03-06
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 3 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 5 · 164 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A062662-001 TAZICEF 500MG/VIAL INJECTABLE / INJECTION 1986-03-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A062662-002 TAZICEF 1GM/VIAL INJECTABLE / INJECTION AP 1986-03-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A062662-003 TAZICEF 2GM/VIAL INJECTABLE / INJECTION AP 1986-03-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A062662-004 TAZICEF 6GM/VIAL INJECTABLE / INJECTION AP 1986-03-06 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A062662-001 TAZICEF 500MG/VIAL INJECTABLE / INJECTION 1986-03-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A062662-002 TAZICEF 1GM/VIAL INJECTABLE / INJECTION AP 1986-03-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A062662-003 TAZICEF 2GM/VIAL INJECTABLE / INJECTION AP 1986-03-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A062662-004 TAZICEF 6GM/VIAL INJECTABLE / INJECTION AP 1986-03-06 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A062662-001 TAZICEF 500MG/VIAL INJECTABLE / INJECTION 1986-03-06 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A062662-002 TAZICEF 1GM/VIAL INJECTABLE / INJECTION AP 1986-03-06 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A062662-003 TAZICEF 2GM/VIAL INJECTABLE / INJECTION AP 1986-03-06 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A062662-004 TAZICEF 6GM/VIAL INJECTABLE / INJECTION AP 1986-03-06 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A062662-001 TAZICEF 500MG/VIAL INJECTABLE / INJECTION 1986-03-06 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A062662-002 TAZICEF 1GM/VIAL INJECTABLE / INJECTION AP 1986-03-06 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A062662-003 TAZICEF 2GM/VIAL INJECTABLE / INJECTION AP 1986-03-06 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A062662-004 TAZICEF 6GM/VIAL INJECTABLE / INJECTION AP 1986-03-06 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A062662-001 TAZICEF 500MG/VIAL INJECTABLE / INJECTION 1986-03-06 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A062662-002 TAZICEF 1GM/VIAL INJECTABLE / INJECTION AP 1986-03-06 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A062662-003 TAZICEF 2GM/VIAL INJECTABLE / INJECTION AP 1986-03-06 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A062662-004 TAZICEF 6GM/VIAL INJECTABLE / INJECTION AP 1986-03-06 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A062662-001 TAZICEF 500MG/VIAL INJECTABLE / INJECTION 1986-03-06 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A062662-002 TAZICEF 1GM/VIAL INJECTABLE / INJECTION AP 1986-03-06 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A062662-003 TAZICEF 2GM/VIAL INJECTABLE / INJECTION AP 1986-03-06 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A062662-004 TAZICEF 6GM/VIAL INJECTABLE / INJECTION AP 1986-03-06 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A062662-001 TAZICEF 500MG/VIAL INJECTABLE / INJECTION 1986-03-06 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A062662-002 TAZICEF 1GM/VIAL INJECTABLE / INJECTION AP 1986-03-06 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A062662-003 TAZICEF 2GM/VIAL INJECTABLE / INJECTION AP 1986-03-06 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A062662-004 TAZICEF 6GM/VIAL INJECTABLE / INJECTION AP 1986-03-06 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A062662-001 TAZICEF 500MG/VIAL INJECTABLE / INJECTION 1986-03-06 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A062662-002 TAZICEF 1GM/VIAL INJECTABLE / INJECTION AP 1986-03-06 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A062662-003 TAZICEF 2GM/VIAL INJECTABLE / INJECTION AP 1986-03-06 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A062662-004 TAZICEF 6GM/VIAL INJECTABLE / INJECTION AP 1986-03-06 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A062662-001 TAZICEF 500MG/VIAL INJECTABLE / INJECTION 1986-03-06 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A062662-002 TAZICEF 1GM/VIAL INJECTABLE / INJECTION AP 1986-03-06 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A062662-003 TAZICEF 2GM/VIAL INJECTABLE / INJECTION AP 1986-03-06 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A062662-004 TAZICEF 6GM/VIAL INJECTABLE / INJECTION AP 1986-03-06 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A062662-001 TAZICEF 500MG/VIAL INJECTABLE / INJECTION 1986-03-06 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A062662-002 TAZICEF 1GM/VIAL INJECTABLE / INJECTION AP 1986-03-06 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A062662-003 TAZICEF 2GM/VIAL INJECTABLE / INJECTION AP 1986-03-06 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A062662-004 TAZICEF 6GM/VIAL INJECTABLE / INJECTION AP 1986-03-06 d06236e962d9…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 4 · 142 observed states.
Additional Listing Data#
Finished product Yes
Brand name base TAZICEF
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength CEFTAZIDIME 6 g/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 9M416Z9QNR Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 206423 Internal RxNorm lookup 242800 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0409-5086-11 TAZICEF 10 in 1 CARTON INJECTION, POWDER, FOR SOLUTION 10 30 0409-5086-13 TAZICEF 1 in 1 VIAL, PHARMACY BULK PACKAGE INJECTION, POWDER, FOR SOLUTION 1 30
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded CEFTAZIDIME ACTIVE INGREDIENT 9M416Z9QNR TAZICEF (CEFTAZIDIME) INJECTION, POWDER, FOR SOLUTION [HOSPIRA, INC.] 13 CEFTAZIDIME ANHYDROUS ACTIVE MOIETY DZR1ENT301 TAZICEF (CEFTAZIDIME) INJECTION, POWDER, FOR SOLUTION [HOSPIRA, INC.] 13 SODIUM CARBONATE INACTIVE INGREDIENT 45P3261C7T TAZICEF (CEFTAZIDIME) INJECTION, POWDER, FOR SOLUTION [HOSPIRA, INC.] 13
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0409-5086 TAZICEF (CEFTAZIDIME) INJECTION, POWDER, FOR SOLUTION [HOSPIRA, INC.] 30 Current NDC, Legacy NDC, 2 package rows 20240705_1ab5ae3e-e303-4499-4c89-472d7cc1e46c.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 0409-5086-11 00409508611 10 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (0409-5086-11) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, PHARMACY BULK PACKAGE (0409-5086-13) 2006-04-20 0000-00-00 No No Current 0409-5086-13 00409508613 1 in 1 VIAL, PHARMACY BULK PACKAGE Historical